All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
PHI enters into underwriting commitment with Altium in ongoing exercise of TO 3 warrants
PHI announces that the Company’s largest shareholder Altium and PHI has agreed on an underwriting commitment free-of-charge in the ongoing exercise of warrants of series TO 3.
PostNews: Press Release
Altium S.A. exercised all their obtained warrants TO 3
PHI announces that Altium S.A. exercised all their obtained warrants TO 3.
PostNews: Press Release
The exercise period for warrants of series TO 3 begins today
PHI announces that the exercise period for warrants of series TO 3 begins today.
PostNews: Press Release
The subscription price for warrants of series TO 3 has been set at SEK 3.78 per share
PHI announces that the subscription price for warrants of series TO 3 has been set at SEK 3.78 per share.
PostNews

BioStock: PHI´s CEO comments on latest advancements
BioStock reached out to PHI´s CEO, Patrik Eschricht, to learn more about the visions moving forward.
PostNews: Interim Report

Interim Report 3 2022/23
Sales have continued to grow, with significantly higher cost efficiency. As a result, rolling 12-month sales gained to its highest level ever.